ORTX
Orchard Therapeutics plc
Halal Rating :
Last Price
$16.70
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Orchard Therapeutics is a global gene therapy company focused on developing potentially curative treatments for patients suffering from rare diseases. The company's ex vivo autologous gene therapy approach utilizes genetically modified blood stem cells to treat genetic diseases. Their pipeline includes treatments for metachromatic leukodystrophy (MLD), Wiskott-Aldrich syndrome (WAS), and other rare genetic conditions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2023 | $6.3m | $28.84m | - | $932000.0 | 0.00% | 3.23% |
| June 30, 2023 | $7.31m | $30.85m | - | $975000.0 | 0.00% | 3.16% |
| March 31, 2023 | $1.24m | $28.45m | - | $957000.0 | 0.00% | 3.36% |
Company Impact
Help us evaluate Orchard Therapeutics plc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.